← Back to Search

Other

Ankle Exoskeleton Assistance for Aging

N/A
Waitlist Available
Led By Gregory S Sawicki, Ph.D.
Research Sponsored by Georgia Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is testing if an ankle exoskeleton can help reduce the amount of energy older adults use when walking, in order to understand why older adults use more energy when walking than young adults.

Who is the study for?
This trial is for healthy adults who can walk for an hour within a 90-minute period. It's open to two age groups: young adults aged 18-45 and seniors aged 65 or older, without cardiovascular, metabolic, renal diseases, musculoskeletal injuries, or respiratory problems.Check my eligibility
What is being tested?
The study aims to understand why older adults use more energy while walking compared to younger ones and attempts to reduce this energy expenditure using an ankle exoskeleton device that enhances muscle contractions during walking.See study design
What are the potential side effects?
While the trial does not mention specific side effects of using the ankle exoskeleton, potential risks may include discomfort at the site of wearing the device or muscle fatigue due to altered walking patterns.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Metabolic rate (watts)
Secondary outcome measures
Preferred walking speed (m/s)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Economical muscle dynamicsExperimental Treatment1 Intervention
The investigators are trying to figure out how to optimize muscle contractile conditions for mobility. To do this, the investigators are systematically altering muscle contraction conditions for all participants.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Strengthening muscle contractions during walking
2020
N/A
~30

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,005,086 Total Patients Enrolled
160 Trials studying Aging
75,979 Patients Enrolled for Aging
Georgia Institute of TechnologyLead Sponsor
48 Previous Clinical Trials
5,506 Total Patients Enrolled
4 Trials studying Aging
236 Patients Enrolled for Aging
Gregory S Sawicki, Ph.D.Principal InvestigatorGeorgia Institute of Technology

Media Library

Ankle Exoskeleton Assistance (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04033146 — N/A
Aging Research Study Groups: Economical muscle dynamics
Aging Clinical Trial 2023: Ankle Exoskeleton Assistance Highlights & Side Effects. Trial Name: NCT04033146 — N/A
Ankle Exoskeleton Assistance (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04033146 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study still recruiting participants?

"This clinical trial, which was initially posted on February 4th 2020 and recently updated on August 18th 2022, is looking for participants. All pertinent information can be found at the website of clinicaltrials.gov."

Answered by AI

How many participants have been recruited for this investigation?

"Affirmative. According to clinicaltrials.gov, this experiment is still taking in new participants since it was posted on February 4th 2020 and last amended on August 18th 2022. The research team seeks 30 persons from one medical center for the trial."

Answered by AI
~5 spots leftby Apr 2025